Edwards Lifesciences (EW) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.94 Bn | 194.34 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 129.96 Bn | 126.49 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 120.01 Bn | 110.79 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.40 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 34.02 Bn | 31.91 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 5.69% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 2.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.67% |
| Mar 31, 2026 | 7.35% |
| Dec 31, 2025 | 7.47% |
| Sep 30, 2025 | 4.03% |
| Jun 30, 2025 | 5.27% |
| Mar 31, 2025 | -3.94% |
| Dec 31, 2024 | 5.97% |
| Sep 30, 2024 | -0.33% |
| Jun 30, 2024 | -1.33% |
| Mar 31, 2024 | 7.41% |
| Dec 31, 2023 | -2.56% |
| Sep 30, 2023 | 7.34% |
| Jun 30, 2023 | 6.56% |
| Mar 31, 2023 | 6.04% |
| Dec 31, 2022 | 5.57% |
| Sep 30, 2022 | 6.95% |
| Jun 30, 2022 | 7.89% |
| Mar 31, 2022 | 9.47% |
| Dec 31, 2021 | 10.85% |
| Sep 30, 2021 | 14.75% |